Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Breast Neoplasms, Male × seviteronel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Neoplasm Metastasis 2 Triple Negative Breast Neoplasms 1 Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

seviteronel 1 ribociclib 1 methyl N-acetylsibirosaminide 1 exemestane 1 Suspensions 1 Presenilin-1 1 Pemetrexed 1 Leuprolide 1 Letrozole 1 Injections 1 Goserelin 1 Fentanyl 1 90Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02580448 2019-02-01

CLARITY-01

Innocrin Pharmaceutical

Phase 1/2 Completed

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡